Clinical Trial Update: STOP Heart Disease in Breast Cancer Survivors Trial [Phase 2]

View source ↗

Summary

A Phase 2 trial investigating strategies to prevent or mitigate cardiotoxicity in breast cancer survivors; the study is terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Heart Disease

Snippet

Sponsor: Cedars-Sinai Medical Center | Conditions: Breast Cancer, Heart Disease | Phase 2 | Status: TERMINATED | Results posted: 2019-04-30